Please login to the form below

Not currently logged in
Email:
Password:

Spiolto Respimat

This page shows the latest Spiolto Respimat news and features for those working in and with pharma, biotech and healthcare.

Boehringer Ingelheim returns to growth after US turnaround

Boehringer Ingelheim returns to growth after US turnaround

fibrosis treatmentRespimat in COPD and Spiriva Respimat for asthma.

Latest news

  • Boehringer hails its 'landmark year' in respiratory Boehringer hails its 'landmark year' in respiratory

    We are also looking at Spiriva Respimat in paediatric asthma patients because there is an unmet medical need there.”. ... Spiolto is positioned as offering greater benefits for patients and physicians than Spiriva and was approved in its first European

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics